Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Exel
FDA Inspection
•Exel•March 12, 2019

Exel – FDA Inspection, Mar 12, 2019

Record Details

This FDA Inspection record concerns Exel, with an inspection on March 12, 2019, issued by the Chicago District Office, covering foods & cosmetics.

Company
Exel
Inspection Date
March 12, 2019
Product Type
Foods & Cosmetics
Office
Chicago District Office
View Company Profile

ID · 0b6e3adb-4fb1-478b-8657-742437040012

Inspection Facts

Inspection number
1082984
FDA center
Foods & Cosmetics
Outcome
Form 483 issued

Other FDA inspections of Exel

2
DateClassificationOfficeProject area
January 6, 2025Not classifiedChicago District Office
March 2, 2010NAICenter for Food Safety and Applied NutritionFoodborne Biological Hazards
Other documents for Exel
  • FDA Inspection 1258823 - 2025-01-06
  • FDA Inspection 665248 - 2010-03-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exel
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.